Xu Lab
Center for Molecular Oncology and Cellular Therapeutics (MOCT)
Children's Mercy Research Institute, Kansas City, MO
Engineering AI-driven platforms and ionizable lipid nanoparticles to transform nucleic acid delivery into precision medicine for pediatric cancer and genetic diseases.
Research Focus
All research → Lipid Nanoparticle Engineering
Combinatorial ionizable-lipid libraries built on automated self-driving platforms, generating standardized structure–activity datasets.
Learn more →AI for Drug Delivery
Foundation models trained on these datasets to discover and optimize lipids with tunable organ tropism.
Learn more →Gene Therapeutics
Organ-targeted carriers translated into precise in vivo nucleic acid medicines against pediatric tumors.
Learn more →
| Oct 2026 | Yue Xu has been selected as an editorial board member of Bioconjugate Chemistry (ACS). Kansas City, MO, USA |
|---|---|
| Oct 2026 | The Xu Lab has been selected as a Research Pilot Project Leader in the Kansas Institute for Precision Medicine COBRE. Kansas City, KC, USA |
| Aug 2026 | Welcome Yukuan (Andy) Pan joined the Children’s Mercy Research Institute as a data scientist Kansas City, MO, USA |